J. Rello, E. Afonso, T. Lisboa, M. Ricart, B. Balsera, A. Rovira, J

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Charles D. Burger, MD, Roger K. Resar, MD Mayo Clinic Proceedings

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J. R. Masclans, M. Pérez, J. Almirall, L. Lorente, A. Marqués, L

P. Melin Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Charles D. Burger, MD, Roger K. Resar, MD Mayo Clinic Proceedings

Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia F.P. Paling, M. Wolkewitz, L.G.M. Bode, P.M.C.

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia

Migrant health—a cause for concern?

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gastroenteritis outbreak caused by norovirus associated with the children's club of a hotel located in Majorca, Spain A. Doménech-Sánchez Clinical Microbiology.

Candida glabrata fungaemia in intensive care units

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Virological tools to diagnose and monitor hepatitis C virus infection

Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics and risk factors M.-H. Tsai, S.-M. Chu, C.-W. Lee,

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

Surveillance of Legionnaires’ disease in Austria

Targeted antibiotic management of ventilator-associated pneumonia

Vector control: a cornerstone in the malaria elimination campaign

Training for the infectious diseases speciality in Norway

G. Höffken Clinical Microbiology and Infection

Community-acquired pneumonia: the evolving challenge

B. Gordts Clinical Microbiology and Infection

Levofloxacin in the treatment of ventilator-associated pneumonia

Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose P. Savard, T.M. Perl Clinical Microbiology.

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Previously unknown species of Aspergillus

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors

Antibacterial drug discovery in the 21st century

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Reducing antibiotic use in influenza: challenges and rewards

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Statin use and clinical outcomes among pneumonia patients

G. De Angelis, A. Murthy, J. Beyersmann, S. Harbarth

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Serum ferritin levels in West Nile encephalitis

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia F.P. Paling, M. Wolkewitz, L.G.M. Bode, P.M.C.

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

A care bundle approach for prevention of ventilator-associated pneumonia J. Rello, E. Afonso, T. Lisboa, M. Ricart, B. Balsera, A. Rovira, J. Valles, E. Diaz Clinical Microbiology and Infection Volume 19, Issue 4, Pages 363-369 (April 2013) DOI: 10.1111/j.1469-0691.2012.03808.x Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Rates of compliance with bundle variables in the intervention period. Clinical Microbiology and Infection 2013 19, 363-369DOI: (10.1111/j.1469-0691.2012.03808.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Ventilator-associated pneumonia (VAP) risk odds ratio for each preventive measure. Clinical Microbiology and Infection 2013 19, 363-369DOI: (10.1111/j.1469-0691.2012.03808.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Intensive-care unit length of stay (LOS) and duration of mechanical ventilation (MV), in days, according to measure compliance—figures after the intervention. Clinical Microbiology and Infection 2013 19, 363-369DOI: (10.1111/j.1469-0691.2012.03808.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 4 Ventilator-associated pneumonia (VAP) incidence (episodes/1000 mechanical ventilation days) for early-onset and late-onset VAP according to measure compliance—figures after the intervention. Clinical Microbiology and Infection 2013 19, 363-369DOI: (10.1111/j.1469-0691.2012.03808.x) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions